Genmab A/S
$274.96
24H
Market Cap
Volume
Supply
Price Chart
About Genmab A/S - GMAB.CO
Genmab A/S is a Denmark-based biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. They are known for their proprietary antibody technology platforms which have produced a range of products both independently and in collaboration with pharmaceutical partners.
What are Genmab A/S's core values and mission statement?
Genmab A/S's core values are centered around passion for innovation, determination, integrity, and collaboration, aiming to transform cancer treatment by creating and developing innovative antibody therapeutics for patients. Their mission is to improve the lives of cancer patients by creating and developing differentiated antibody therapeutics.
Who founded Genmab A/S and when?
Genmab A/S was founded by Florian Schönharting and Van de Winkel in 1999.
Who leads Genmab A/S?
As of my last update, Jan van de Winkel serves as the CEO of Genmab A/S.
Where is Genmab A/S located, and what is its base country?
Genmab A/S is headquartered in Copenhagen, Denmark.
On which exchanges is Genmab A/S traded?
Genmab A/S is primarily traded on the Nasdaq Copenhagen under the ticker symbol "GMAB." It is also listed on the Nasdaq Stock Market in the United States under the ticker symbol "GMAB."
Historical data
Genmab A/S (GMAB) Price Live Data
The live price of Genmab A/S (GMAB) is $274.96, with a trading volume of 46,375 in the last 24 hours. Wrapstocks updates the GMAB price in real-time. Genmab A/S is up 1.17% in the last 24 hours. The company has a live market cap of $17,450,588,108.80 and a supply of 63,465,899 GMAB stocks.
Genmab A/S (GMAB) is traded on Copenhagen Stock Exchange, and currently, the market is closed; trading will be resumed in 5 hours and 46 minutes.
